Balyasny Asset Management
CLMT icon

Balyasny Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Balyasny Asset Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Buy
8,758
+1,540
+21% +$51.8K ﹤0.01% 2695
2026
Q1 		$259K Buy
+7,218
New +$187K ﹤0.01% 2617
2025
Q2 		– Sell
-73,768
Closed -$935K – 2886
2025
Q1 		$935K Buy
+73,768
New +$1.16M ﹤0.01% 2020
2016
Q1 		– Sell
-85,200
Closed -$1.7M – 1298
2015
Q4 		$1.7M Sell
85,200
-29,782
-26% -$736K 0.01% 666
2015
Q3 		$2.79M Buy
+114,982
New +$2.99M 0.02% 620

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Balyasny Asset Management's CLMT Position: Q2 2026 in Review

Balyasny Asset Management increased its Calumet Specialty Products (CLMT) stake by 21% in Q2 2026, buying an estimated $51.8K and bringing the position to 8,758 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

Balyasny Asset Management first reported a position in CLMT in Q3 2015 and has held it in 5 quarters since. The position peaked at $2.79M in Q3 2015. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Balyasny Asset Management held 8,758 shares of Calumet Specialty Products worth $315K as of Q2 2026.
  • Balyasny Asset Management bought 1,540 Calumet Specialty Products shares in Q2 2026, an estimated $51.8K.
  • Calumet Specialty Products made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2695 holding.
  • Balyasny Asset Management first reported a position in Calumet Specialty Products in Q3 2015 and has held it in 5 quarters since.
  • Balyasny Asset Management's Calumet Specialty Products position peaked at $2.79M in Q3 2015.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.